Literature DB >> 24699311

Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.

Frank Musshoff1, Eva Große Hokamp2, Ulrich Bott3, Burkhard Madea2.   

Abstract

There is a need for quick and reliable methods for rapid screening of drug-influenced drivers on the roadside by police. Because the window of detection in oral fluid is more similar to blood than to urine, this matrix should therefore be appropriate for screening procedures. The performance of the Rapid STAT(®) (Mavand Solution GmbH, Mössingen, Germany), DrugWipe5/5+(®) (Securetec Detektions-Systeme AG, Brunnthal, Germany) and Dräger DrugTest(®) 5000 (Draeger Safety AG & Co. KGaA, Luebeck, Germany) on-site oral fluid devices was evaluated with random oral fluid specimens from car drivers in North Rhine-Westphalia (Germany). Additionally, some drivers were checked using an on-site urine device (DrugScreen(®), NAL von Minden, Regensburg, Germany). During a 11-month period, 1.212 drivers were tested. Both OF and urine on-site tests were compared to serum results. The following sensitivities were obtained by the oral fluid devices: THC 71% (DrugWipe(®)), 87% (Dräger), 91% (RapidSTAT); opiates 95% (Dräger), 100% (DrugWipe(®), RapidSTAT(®)); amphetamine 84% (DrugTest(®) 5000), 90% (RapidSTAT(®)), 100% (DrugTest(®) 5000); methamphetamine 50% (DrugTest(®) 5000), 100% (RapidSTAT(®)); cocaine 76% (DrugTest(®) 5000), 100% (DrugWipe(®), RapidSTAT(®)); methadone 33-63%, and benzodiazepines 0-33% (both with a low number of positives). THC specificity was especially low (29% [DrugWipe(®)] and 47% [DrugTest(®) 5000]) due to low cut-off concentrations. These data were similar to those obtained from the literature (e.g., DRUID project). The urine screening device showed a good sensitivity (THC 93%, opiate 94%, amphetamine 94%, methamphetamine 75% (low number of positives), cocaine 100%) and also an acceptable specificity (39%, 86%, 63%, 77%, 47%, respectively). Although oral fluid may be a useful matrix for on-site testing of drugged drivers, it is evident that oral fluid devices still show a lack of sensitivity (methamphetamine, benzodiazepines) and specificity (THC). Poor results for benzodiazepines may be explained by the small positive test number. Although the sensitivity for THC came out higher than compared to the literature, specificity is not yet satisfactory (only <90%). Furthermore, specificity was poor due to lowered cut-offs resulting in multiple false positive tests.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Blood/serum; Chromatography; Driving under influence of drugs (DUID); Immunoassay; On-site drug testing urine; Oral fluid

Mesh:

Substances:

Year:  2014        PMID: 24699311     DOI: 10.1016/j.forsciint.2014.02.005

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  10 in total

1.  Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration.

Authors:  Matthew N Newmeyer; Marta Concheiro; Jose Luiz da Costa; Ronald Flegel; David A Gorelick; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-03-18       Impact factor: 3.345

2.  Long-term stability of cannabinoids in oral fluid after controlled cannabis administration.

Authors:  Karl B Scheidweiler; Maria Andersson; Madeleine J Swortwood; Cristina Sempio; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2016-09-13       Impact factor: 3.345

3.  Direct drug analysis from oral fluid using medical swab touch spray mass spectrometry.

Authors:  Valentina Pirro; Alan K Jarmusch; Marco Vincenti; R Graham Cooks
Journal:  Anal Chim Acta       Date:  2015-01-07       Impact factor: 6.558

Review 4.  Correlation between Blood and Oral Fluid Psychoactive Drug Concentrations and Cognitive Impairment in Driving under the Influence of Drugs.

Authors:  Francesco Paolo Busardo; Simona Pichini; Manuela Pellegrini; Angelo Montana; Alfredo Fabrizio Lo Faro; Simona Zaami; Silvia Graziano
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  Challenges in studying statewide pedestrian injuries and drug involvement.

Authors:  Elizabeth D Nesoff; Charles C Branas; Silvia S Martins
Journal:  Inj Epidemiol       Date:  2018-12-03

6.  Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point-of-collection testing devices.

Authors:  Thomas R Arkell; Richard C Kevin; Jordyn Stuart; Nicholas Lintzeris; Paul S Haber; Johannes G Ramaekers; Iain S McGregor
Journal:  Drug Test Anal       Date:  2019-09-10       Impact factor: 3.345

7.  Positivity to Cocaine and/or Benzoylecgonine in Confirmation Analyses for On-Road Tests in Spain.

Authors:  Francisco Herrera-Gómez; Eduardo Gutiérrez-Abejón; Mercedes García-Mingo; F Javier Álvarez
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

Review 8.  Analytical Methods Used for the Detection and Quantification of Benzodiazepines.

Authors:  Zidane Qriouet; Zineb Qmichou; Nadia Bouchoutrouch; Hassan Mahi; Yahia Cherrah; Hassan Sefrioui
Journal:  J Anal Methods Chem       Date:  2019-09-05       Impact factor: 2.193

9.  Benzodiazepines in the oral fluid of Spanish drivers.

Authors:  Francisco Herrera-Gómez; Mercedes García-Mingo; F Javier Álvarez
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-02-24

Review 10.  Saliva, a bodily fluid with recognized and potential diagnostic applications.

Authors:  Mozhgan Boroumand; Alessandra Olianas; Tiziana Cabras; Barbara Manconi; Daniela Fanni; Gavino Faa; Claudia Desiderio; Irene Messana; Massimo Castagnola
Journal:  J Sep Sci       Date:  2021-08-18       Impact factor: 3.614

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.